Monday, November 15, 2021
Clinical Trial of an Original Russian Drug for the Treatment of Lung Cancer Starts in China
A Joint Venture Company of BIOCAD and Shanghai Pharmaceuticals Holding announced the enrollment of the first Chinese patient in Phase III international multicenter clinical trial of prolgolimab